Therapeutic development and careers in medicine rarely follow a straight line. They often take shape through unexpected opportunities.
This theme characterized a fireside chat between Dr. Robert A. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University, and Dr. John Babich, president and chief scientific officer of Ratio Therapeutics, at Weill Cornell’s 10th annual Dean’s Symposium on Innovation and Entrepreneurship. The event, held Nov. 11, convened researchers, clinicians, students and entrepreneurs to explore how academic discoveries can reach patients through commercial, collaborative and entrepreneurial support.
“The path toward tangible impact for research happening here at Weill Cornell Medicine is through commercialization,” said Dr. Lisa Placanica, senior managing director of the Center for Technology Licensing (CTL) at Weill Cornell. “It’s taking the fundamental research outputs from researchers, trainees and clinicians and working with commercial entities of all kinds—whether that’s starting new companies, collaborating with existing companies or having research alliances—to translate that research into tangible products that can really benefit patients.”